Biomarkers of cardiovascular disease risk in women

Metabolism: Clinical and Experimental

Volumn 64, Issue 3, 2015, Pages S33-S39

  Manson, Joann E ^a   Bassuk, Shari S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Biomarkers; Cardiovascular disease; Coronary risk factors; Risk prediction; Women

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; BIOLOGICAL MARKER; CALCIUM; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; NATRIURETIC FACTOR; TROPONIN; APOA1 PROTEIN, HUMAN; APOLIPOPROTEIN B; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TROPONIN T;

ACUTE CORONARY SYNDROME; AGE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DYSGLYCEMIA; FEMALE; GENETIC MARKER; HORMONAL REGULATION; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; OBESITY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SMOKING; BLOOD; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASES; COMPLICATION; MALE; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOMARKERS; BODY FAT DISTRIBUTION; CALCIUM; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; METABOLIC SYNDROME X; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; TROPONIN T;

EID: 84920943516     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.10.028     Document Type: Article

References (36)

1. A.S. Go, D. Mozaffarian, and V.L. Roger Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
2. L. Mosca, E.J. Benjamin, and K. Berra Effectiveness-based guidelines for the prevention of cardiovascular disease in women - 2011 update: a guideline from the American Heart Association Circulation 123 2011 1243 1262
3. D.M. Lloyd-Jones, E.P. Leip, and M.G. Larson Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 2006 791 798
4. J.D. Berry, A. Dyer, and X. Cai Lifetime risks of cardiovascular disease N Engl J Med 366 2012 321 329
5. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
6. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final Report Circulation 106 2002 3143 3421
7. R.B. D'Agostino Sr., R.S. Vasan, and M.J. Pencina General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 2008 743 753
8. M.J. Pencina, R.B. D'Agostino Sr., M.G. Larson, J.M. Massaro, and R.S. Vasan Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study Circulation 119 2009 3078 3084
9. D.C. Goff Jr., D.M. Lloyd-Jones, and G. Bennett 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 2014 S49 73
10. M.J. Blaha, and R.S. Blumenthal Risk factors: new risk-assessment guidelines - more or less personalized? Nat Rev Cardiol 11 2014 136 137
11. N.P. Amin, S.S. Martin, M.J. Blaha, K. Nasir, R.S. Blumenthal, and E.D. Michos Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines J Am Coll Cardiol 63 2014 2789 2794
12. P.M. Ridker, J.E. Buring, N. Rifai, and N.R. Cook Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score JAMA 297 2007 611 619
13. P.M. Ridker, N.P. Paynter, N. Rifai, J.M. Gaziano, and N.R. Cook C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men Circulation 118 2008 2243 2251
14. N.R. Cook, N.P. Paynter, and C.B. Eaton Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative Circulation 125 1748-56 2012 S1 S11
15. P.M. Ridker, and N.R. Cook Statins: new American guidelines for prevention of cardiovascular disease Lancet 382 2013 1762 1765
16. N.P. Paynter, B.M. Everett, and N.R. Cook Cardiovascular disease risk prediction in women: is there a role for novel biomarkers? Clin Chem 60 2014 88 97
17. A.R. Folsom Classical and novel biomarkers for cardiovascular risk prediction in the United States J Epidemiol 23 2013 158 162
18. A. Thompson, and J. Danesh Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies J Intern Med 259 2006 481 492
19. E. Di Angelantonio, P. Gao, and L. Pennells Lipid-related markers and cardiovascular disease prediction JAMA 307 2012 2499 2506
20. S. Erqou, S. Kaptoge, and P.L. Perry Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 2009 412 423
21. 2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies Lancet 375 2010 1536 1544
22. 2 for cardiovascular disease prediction in a multiethnic cohort of women Clin Chem 58 2012 1352 1363
23. E. Di Angelantonio, R. Chowdhury, and N. Sarwar B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies Circulation 120 2009 2177 2187
24. S.R. Motiwala, A. Sarma, J.L. Januzzi, and M.L. O'Donoghue Biomarkers in ACS and heart failure: should men and women be interpreted differently? Clin Chem 60 2014 35 43
25. J.T. Saunders, V. Nambi, and J.A. de Lemos Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study Circulation 123 2011 1367 1376
26. C.R. deFilippi, J.A. de Lemos, and R.H. Christenson Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults JAMA 304 2010 2494 2502
27. B.M. Everett, N.R. Cook, and M.C. Magnone Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study Circulation 123 2011 2811 2818
28. T. Zeller, H. Tunstall-Pedoe, and O. Saarela High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort Eur Heart J 35 2014 271 281
29. M.J. Blaha, M.G. Silverman, and M.J. Budoff Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease? Clinical risk scores are not sufficient to define primary prevention treatment strategies among asymptomatic patients Circ Cardiovasc Imaging 7 2014 398 408
30. M. Kavousi, S. Elias-Smale, and J.H. Rutten Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study Ann Intern Med 156 2012 438 444
31. C. Andersson, and R.S. Vasan Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease? Clinical risk scores are sufficient to define primary prevention treatment strategies among asymptomatic patients Circ Cardiovasc Imaging 7 2014 390 397
32. A. Tufano, A. Guida, and A. Coppola Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis Blood Transfus 12 Suppl. 1 2014 s337 s342
33. A.D. Pradhan Sex differences in the metabolic syndrome: implications for cardiovascular health in women Clin Chem 60 2014 44 52
34. A. Mozumdar, and G. Liguori Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006 Diabetes Care 34 2011 216 219
35. J.L. Kuk, and C.I. Ardern Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk Diabetes Care 33 2010 2457 2461
36. Bassuk SS, Manson JE. Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes. Ann Epidemiol, in press.